The FDA has confirmed there is no legal basis for compounding pharmacies to include BPC-157 in compounded medications
Andrew Huberman: So I can imagine that vasodilation, getting more perfusion of blood to the brain, plus a little bit of stress or maybe a lot of stress from the epinephrine
Tirzepatide is administered by once-weekly injection, starting with 2.5 mg weekly and increasing after 4 weeks to 5 mg weekly
Both products use the same molecule (semaglutide), the same dose strengths (0.25 mg, 0.5 mg, 1.0 mg, 2.0 mg) and the same pre-filled pen device
28 (The Controlled Substances Act empowers the Attorney General to temporarily place a substance into Schedule I for two years without regard to other administrative requirements if there is a finding that such action is necessary to avoid an imminent hazard to the public safety.) This decision was based, in part, on the DEAs finding that the severity of the reported outcomes, health effects, and increased use of kratom suggests an emerging public health threat. 28 Organizations promoting kratom use did not receive this decision favorably
J.TruongT